Introducing the Adaptive Thrombectomy Platform

One simple mechanism that adapts to the clot, the vessel, and the site of care.

Peripheral thrombectomy has outgrown the single-purpose device. Aspiration catheters suction, mechanical devices drag, and lytics dissolve. Each works well when the case matches its design. When it doesn’t, physicians switch devices, add lytics, or move the patient to the OR. The result is a vascular lab stocked with multiple systems, each with its own technique, sizes, consoles, adapters, contracts, and rep dependence.

Peripheral clots rarely match a single device category. Acute and organized thrombus often share the same vessel, diameters change along the way, and many patients can’t tolerate lytics or blood loss. That’s why most labs end up juggling multiple systems, consoles, and contracts.

The market is primed and ready for a different approach: the Adaptive Thrombectomy Platform. iSWEEP™ makes the 60-year-proven Fogarty balloon sweep endovascular, with one consistent method (Protect. Sweep. Capture. Remove.) that scales across anatomies.

  • Arterial (iART 7F): 100% technical success, 94% clinical success, and no device-related adverse events in a 25-patient limited market release
  • Venous (iDVT 14F): 90% estimated clot removal, 94% clinical success, and ~31 minutes access to reperfusion in early data from 80 patients, with no systemic lytics and little to no blood loss
  • Site of care: No capital equipment or console, one kit per case, practical for hospitals, ASCs / OBLs, and a global economic solution.

This new category has four defining traits

  1. One proven mechanism, many anatomies. A single, consistent method of clot removal across a wide range of vessel types and sizes.

  2. Adapts to the clot. Treats acute, subacute, and organized thrombus without relying on suction power, surgery, or clot-dissolving drugs.

  3. Protects the vessel. Gentle, circumferential wall-to-wall contact with built-in embolic protection.

  4. Adapts to the site of care. No capital equipment, console, blood buckets, or adapters, so it works in the hospital, ASC, and office-based lab.

iSWEEP™ by iCHOR Vascular was designed from the ground up to meet all four.

Who benefits

  • Physicians: One technique to learn and trust, with confidence that carries from case to case and anatomy to anatomy, as a primary option or alongside aspiration.

  • Patients: Clot removal that protects the vessel and limits blood loss, without the bleeding risk of lytics or the recovery time of open surgery.

  • Administrators and sites of care: One kit per case, no capital investment, fewer SKUs and contracts, and no need for a rep in the room.

iSWEEP is the first of its kind, in a category of its own.

Read the full paper: Introducing the Adaptive Thrombectomy Platform